BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22075327)

  • 21. Homoharringtonine, aclarubicin and cytarabine (HAA) regimen as the first course of induction therapy is highly effective for acute myeloid leukemia with t (8;21).
    Zhu HH; Jiang H; Jiang Q; Jia JS; Qin YZ; Huang XJ
    Leuk Res; 2016 May; 44():40-4. PubMed ID: 26994850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment of a novel human myeloid leukaemia cell line (HNT-34) with t(3;3)(q21;q26), t(9;22)(q34;q11) and the expression of EVI1 gene, P210 and P190 BCR/ABL chimaeric transcripts from a patient with AML after MDS with 3q21q26 syndrome.
    Hamaguchi H; Suzukawa K; Nagata K; Yamamoto K; Yagasaki F; Morishita K
    Br J Haematol; 1997 Aug; 98(2):399-407. PubMed ID: 9266939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reciprocal t(9;22) ABL/BCR fusion proteins: leukemogenic potential and effects on B cell commitment.
    Zheng X; Oancea C; Henschler R; Moore MA; Ruthardt M
    PLoS One; 2009 Oct; 4(10):e7661. PubMed ID: 19876398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blastic phase chronic myeloid leukemia with a four-break rearrangement: t(11;9)(9;22)(q23;p22q34;q11).
    Li L; Ritterbach J; Harbott J; Schroyens W; Lohmeyer J; Pralle H; Lampert F
    Cancer Genet Cytogenet; 1993 Jul; 68(2):131-4. PubMed ID: 8353804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Translocation of BCR to chromosome 9 in a Philadelphia-negative chronic myeloid leukemia.
    Brunel V; Sainty D; Costello R; Mozziconacci MJ; Simonetti J; Arnoulet C; Coignet L; Bouabdallah R; Gastaut JA; Gabert J
    Cancer Genet Cytogenet; 1995 Nov; 85(1):82-4. PubMed ID: 8536245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cladribine with Granulocyte Colony-Stimulating Factor, Cytarabine, and Aclarubicin Regimen in Refractory/Relapsed Acute Myeloid Leukemia: A Phase II Multicenter Study.
    Wang H; Wang L; Li C; Wuxiao Z; Shao R; Wang H; Lu Y
    Oncologist; 2020 Nov; 25(11):e1663-e1670. PubMed ID: 32845551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular analysis of a case of Philadelphia chromosome-positive acute myeloid leukemia.
    Yoshida A; Kishi S; Kita K; Kamada N; Nakamura T; Ueda T
    Anticancer Res; 1997; 17(1B):625-8. PubMed ID: 9066590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel Variant t(1;22) Translocation - ins(22;1)(q13;p13p31) - in a Child with Acute Megakaryoblastic Leukemia.
    Margolskee E; Saab J; Geyer JT; Aledo A; Mathew S
    Am J Case Rep; 2017 Apr; 18():422-426. PubMed ID: 28420865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cryptic BCR-ABL fusion gene as variant rearrangement in chronic myeloid leukemia: molecular cytogenetic characterization and influence on TKIs therapy.
    Luatti S; Baldazzi C; Marzocchi G; Ameli G; Bochicchio MT; Soverini S; Castagnetti F; Tiribelli M; Gugliotta G; Martinelli G; Baccarani M; Cavo M; Rosti G; Testoni N
    Oncotarget; 2017 May; 8(18):29906-29913. PubMed ID: 28404889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molecular basis of the t(1;22)(p13;q13) specific for human acute megakaryoblastic leukemia].
    Mercher T; Courtois G; Berger R; Bernard OA
    Pathol Biol (Paris); 2003 Feb; 51(1):27-32. PubMed ID: 12628289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute megakaryocytic leukemia with the t(1;22)(p13;q13).
    Lion T; Haas OA
    Leuk Lymphoma; 1993 Sep; 11(1-2):15-20. PubMed ID: 8220150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BCR rearrangement without juxtaposition of ABL in pre-T acute lymphoblastic leukaemia.
    Fosså A; Siebert R; Kasper C; Becher R; Opalka B; Thiel E; Seeber S; Nowrousian MR
    Br J Haematol; 1996 May; 93(2):403-5. PubMed ID: 8639438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The t(1;22) (p13;q13) is nonrandom and restricted to infants with acute megakaryoblastic leukemia: a Pediatric Oncology Group Study.
    Carroll A; Civin C; Schneider N; Dahl G; Pappo A; Bowman P; Emami A; Gross S; Alvarado C; Phillips C
    Blood; 1991 Aug; 78(3):748-52. PubMed ID: 1859887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Ph-negative chronic myeloid leukemia with a complex BCR/ABL rearrangement and a t(6;9)(p21;q34.1).
    Todorić-Zivanović B; Marisavljević D; Surace C; Cemerikić V; Marković O; Krtolica K; Tatomirović Z; Cikota B; Magić Z; Rocchi M
    Cancer Genet Cytogenet; 2006 Apr; 166(2):180-5. PubMed ID: 16631477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Successful treatment with G-CSF and continuous infusion of low-dose cytarabine and etoposide for therapy-related acute myeloid leukemia developed during chemotherapy for malignant lymphoma].
    Yamamoto K; Nagata K; Morita Y; Hamaguchi H
    Rinsho Ketsueki; 2002 Jun; 43(6):488-92. PubMed ID: 12134707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of low-dose cytarabine, homoharringtonine and granulocyte colony-stimulating factor priming regimen on patients with advanced myelodysplastic syndrome or acute myeloid leukemia transformed from myelodysplastic syndrome.
    Wu L; Li X; Su J; Chang C; He Q; Zhang X; Xu L; Song L; Pu Q
    Leuk Lymphoma; 2009 Sep; 50(9):1461-7. PubMed ID: 19672772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Translocation of BCR to chromosome 9: a new cytogenetic variant detected by FISH in two Ph-negative, BCR-positive patients with chronic myeloid leukemia.
    Hagemeijer A; Buijs A; Smit E; Janssen B; Creemers GJ; Van der Plas D; Grosveld G
    Genes Chromosomes Cancer; 1993 Dec; 8(4):237-45. PubMed ID: 7512367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. t(9;22) as secondary alteration in core-binding factor de novo acute myeloid leukemia.
    Vitale C; Lu X; Abderrahman B; Takahashi K; Ravandi F; Jabbour E
    Am J Hematol; 2015 Nov; 90(11):E211-2. PubMed ID: 26257212
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular cytogenetic characterization of Philadelphia-negative rearrangements in chronic myeloid leukemia patients.
    Bennour A; Bellâaj H; Ben Youssef Y; Elloumi M; Khelif A; Saad A; Sennana H
    J Cancer Res Clin Oncol; 2011 Sep; 137(9):1329-36. PubMed ID: 21739181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia.
    Yaghmaie M; Ghaffari SH; Ghavamzadeh A; Alimoghaddam K; Jahani M; Mousavi SA; Irvani M; Bahar B; Bibordi I
    Arch Iran Med; 2008 May; 11(3):247-51. PubMed ID: 18426313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.